Medical News

RSS

Preterm infants do not get used to repeated pain, study finds

Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study led by UCL (University College London) researchers.

16 Mar 2023

Stimulus-sensitive polymeric micelles show promise for future targeted drug delivery and chemotherapy

Researchers documented the various polymeric materials that can be used to synthesize micelles, which can then be used for targeted cancer therapy by tailoring the micelles to respond to stimuli.

16 Mar 2023

Study highlights a persistent life expectancy gap among patients living with sickle cell disease

While research has long established disparities in health outcomes among individuals living with sickle cell disease (SCD), few studies have quantified these gaps.

16 Mar 2023

Is there an association between COVID-19 and an increased incidence of temporomandibular disorders?

Researchers assessed the association between COVID-19-related stress, depression, anxiety, and temporomandibular disorders from childhood to adulthood.

16 Mar 2023

Scientists develop genetically defined mouse models for multiple myeloma subtypes

A team of scientists led by Martin Janz and Klaus Rajewsky at the Max Delbrück Center has successfully generated genetically defined mouse models for two subtypes of multiple myeloma.

16 Mar 2023

Altered spreading of neuronal avalanches in temporal lobe epilepsy linked to cognitive performance

New research by the Human Brain Project has found that in the brains of patients with epilepsy, changes in large-scale neuronal activations can be detected in the brain's resting state activity, even when no seizure is ongoing.

16 Mar 2023

One-Pot-LAMP: A promising tool for non-small cell lung cancer diagnosis

Researchers assessed the efficiency of a genetic decoding system for diagnosing non-small cell lung cancer (NSCLC).

16 Mar 2023

Multivariate brain-wide associated studies can be replicable with substantially smaller sample sizes

Since the development of functional magnetic resonance imaging in the 1990s, the reliance on neuroimaging has skyrocketed as researchers investigate how fMRI data from the brain at rest, and anatomical brain structure itself, can be used to predict individual traits, such as depression, cognitive decline, and brain disorders.

16 Mar 2023

Global maternal Strep B immunization program may save millions of dollars in healthcare costs

A global maternal immunization program for group B Streptococcus - Strep B - would save millions of dollars in healthcare costs by reducing death and disability, a team led by researchers from the London School of Hygiene & Tropical Medicine has found.

16 Mar 2023

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

More than 37 million Americans have diabetes, and approximately 90-95% have Type 2 diabetes.

16 Mar 2023

A high-throughput CAMP assay for the evaluation of the vitamin D-dependent antimicrobial response

A recent developed a novel and high-throughput assay to evaluate cathelicidin antimicrobial peptide.

16 Mar 2023

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

KAIST (President Kwang Hyung Lee) announced on the 16th that an advanced AI-based drug interaction prediction technology developed by the Distinguished Professor Sang Yup Lee's research team in the Department of Biochemical Engineering that analyzed the interaction between the PaxlovidTM ingredients that are used as COVID-19 treatment and other prescription drugs was published as a thesis.

16 Mar 2023

Maternal opioid treatment after delivery not associated with adverse infant outcomes

Infants born to mothers prescribed opioids after delivery, mostly after a cesarean, are at no greater risk of harm shortly after birth than infants of mothers not prescribed opioids, finds a large study from Canada published by The BMJ today.

16 Mar 2023

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

Albumedix Ltd, Nottingham, United Kingdom, now part of the global life science group Sartorius, and Heartseed Inc ('Heartseed'), Tokyo, Japan, Tuesday 14th March 2023, announce that Recombumin® is a critical component of Heartseed's HS-001, an investigational cardiac remuscularization cell therapy which has commenced first in human dosing.

From Albumedix Ltd. 16 Mar 2023

Medical News

Preterm infants do not get used to repeated pain, study finds

Stimulus-sensitive polymeric micelles show promise for future targeted drug delivery and chemotherapy

Study highlights a persistent life expectancy gap among patients living with sickle cell disease

Is there an association between COVID-19 and an increased incidence of temporomandibular disorders?

Scientists develop genetically defined mouse models for multiple myeloma subtypes

Altered spreading of neuronal avalanches in temporal lobe epilepsy linked to cognitive performance

One-Pot-LAMP: A promising tool for non-small cell lung cancer diagnosis

Multivariate brain-wide associated studies can be replicable with substantially smaller sample sizes

Global maternal Strep B immunization program may save millions of dollars in healthcare costs

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

A high-throughput CAMP assay for the evaluation of the vitamin D-dependent antimicrobial response

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

Maternal opioid treatment after delivery not associated with adverse infant outcomes

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

Forecasting adverse effects and prognosis in TB patients using AI

Common meat-free proteins may trigger allergic complaints in some legume-allergic patients

Listen to ‘Tradeoffs’: Medical debt delivers ‘a shocking amount of misery’

The US remains a grim leader in preterm births. Why? And can we fix it?

Study: Black Americans lost trust in cancer information given out by the government during the pandemic

Short sleep duration at night associated with increased risk of peripheral artery disease

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News